NPs Basic Information

Name
3-hydroxymellein
Molecular Formula C11H12O3
IUPAC Name*
3-methyl-1-methylidene-4H-isochromene-3,8-diol
SMILES
C=C1OC(C)(O)Cc2cccc(O)c21
InChI
InChI=1S/C11H12O3/c1-7-10-8(4-3-5-9(10)12)6-11(2,13)14-7/h3-5,12-13H,1,6H2,2H3/t11-/m1/s1
InChIKey
RUTANJPQCFZRDW-LLVKDONJSA-N
Synonyms
NA
CAS NA
PubChem CID NA
ChEMBL ID NA
*Note: the IUPAC Name was calculated by STOUT. Reference: PMID:33906675.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Organoheterocyclic compou
      • Class: Benzopyrans
        • Subclass: 2-benzopyrans
          • Direct Parent: 2-benzopyrans

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 192.21 ALogp: 1.6
HBD: 2 HBA: 3
Rotatable Bonds: 0 Lipinski's rule of five: Accepted
Polar Surface Area: 49.7 Aromatic Rings: 2
Heavy Atoms: 14 QED Weighted: 0.662

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -4.49 MDCK Permeability: 0.00003580
Pgp-inhibitor: 0 Pgp-substrate: 0.001
Human Intestinal Absorption (HIA): 0.006 20% Bioavailability (F20%): 0.02
30% Bioavailability (F30%): 0.524

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.759 Plasma Protein Binding (PPB): 78.39%
Volume Distribution (VD): 1.052 Fu: 15.37%

ADMET: Metabolism

CYP1A2-inhibitor: 0.883 CYP1A2-substrate: 0.472
CYP2C19-inhibitor: 0.233 CYP2C19-substrate: 0.285
CYP2C9-inhibitor: 0.169 CYP2C9-substrate: 0.814
CYP2D6-inhibitor: 0.43 CYP2D6-substrate: 0.478
CYP3A4-inhibitor: 0.281 CYP3A4-substrate: 0.248

ADMET: Excretion

Clearance (CL): 11.974 Half-life (T1/2): 0.455

ADMET: Toxicity

hERG Blockers: 0.012 Human Hepatotoxicity (H-HT): 0.109
Drug-inuced Liver Injury (DILI): 0.436 AMES Toxicity: 0.172
Rat Oral Acute Toxicity: 0.14 Maximum Recommended Daily Dose: 0.032
Skin Sensitization: 0.521 Carcinogencity: 0.639
Eye Corrosion: 0.013 Eye Irritation: 0.605
Respiratory Toxicity: 0.044
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC004794 0.583 D0H6QU 0.267
ENC000584 0.423 D07HBX 0.250
ENC002082 0.423 D08NQZ 0.232
ENC000856 0.423 D0H1AR 0.232
ENC003031 0.418 D09OQV 0.229
ENC005091 0.390 D04EYC 0.228
ENC004829 0.386 D0WE3O 0.225
ENC003945 0.386 D0O6IU 0.224
ENC005104 0.382 D0A3HB 0.220
ENC002975 0.370 D02NSF 0.220
*Note: the compound similarity was calculated by RDKIT.